Tag: c60


Ichor awarded $80,000 grant for oncology research

LaFayette, NY (PRWEB) July 07, 2015 Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced today that it has received $79,775 in new grant funding from Methuselah Foundation, a 501(c)3 non-profit that funds regenerative medicine R&D. This news comes in response to pilot studies completed at Ichor during winter 2014-2015 where c60oo administration doubled

Read more